甘肃亚太实业发展股份有限公司第九届董事会第二十二次会议决议公告

Group 1 - The company held its 22nd meeting of the 9th Board of Directors on January 22, 2026, via telecommunication, with all 9 directors present, and the meeting was chaired by Chairman Chen Zhijian [2][3] - The Board approved the proposal regarding the expected daily related transactions for January-February 2026, which will involve a maximum amount of 22.19 million yuan [9][10] - The independent directors reviewed and approved the proposal, stating that the expected transactions are necessary for the company's operations and will not adversely affect its independence or harm the interests of shareholders [10][21] Group 2 - The expected daily related transactions will occur with Hebei Yanuo Biotechnology Group Co., Ltd. and its subsidiaries, which are controlled by the current director Liu Xiaomin [8][19] - The transactions are based on market prices and adhere to fair pricing principles, ensuring that they do not harm the company's interests [21][23] - The company has a good credit status and a history of fulfilling obligations in past transactions with the related parties [20]